ORTEXORTEX News
Tracking ONC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
ON

BeOne Medicines AG (ONC) short interest & options flow

NASDAQ

ONC reported Q3 results on November 5 and gained nearly 10% on the week to close at $406.96, with the stock up 5.1% on Friday alone as analysts revised targets higher across the board. The post-earnings upgrade wave was broad and uniform. RBC Capital, Truist Securities, Barclays, Citizens, and Wells Fargo all raised price targets on November 6, with not one firm cutting its rating…

Latest pulse2 Oct 2026

ONC short interest jumped 20.6% over the past week to 1.61% of free float, driven by director Wang Xiaodong's sustained selling activity under a 10b5-1 plan totalling over $11.3 million on 28 September.

$419.98-0.95% 1d+11.17% 1w+18.48% 1mClose: 11 Nov 2026
Short interest % of float
Low and dropping
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Availability
High
Live availability on ORTEX →
Market cap
$47.97B
Next earnings
25 Mar 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of BeOne Medicines AG (ONC) share price and short interest (% of free float), six months to November 11, 2026

ONC news and analysis

RSS

Want the live picture for ONC?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ONC — free to start on ORTEX.

Sign up for free →Open ONC on ORTEX